← Insider buys
ALXN

Alexion Pharmaceuticals, Inc.

EVP and Chief Compliance Officer Indrani Lall Franchini sold $598K of Alexion Pharmaceuticals, Inc.

Sold$597,510
$132.78Price
4,500Shares
−13%Stake

What ALXN did after the filing

Prices for ALXN after this filing aren't in yet.

Traded Mon, Jul 1. Filed Tue, Jul 2, 12:41 PM ET, during the session. Not investment advice.